EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions

Reisuke Yoshizawa iD

Pacing and Clinical Electrophysiology · 2026-11 · 49 (11) · 1772-1781

DOI: 10.1111/pace.70402 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pacing and Clinical Electrophysiology, online erschienen am 19.08.2026. Verfasst von Reisuke Yoshizawa. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan. Hauptthemen laut MEDLINE: Heart Defects, Congenital, Cardiac Pacing, Artificial, Bundle of His. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Left bundle branch area pacing (LBBAP) has emerged as a promising alternative to right ventricular apical pacing in patients with congenital heart disease (CHD), yet its application in this population remains underexplored despite unique anatomical and physiological challenges. This review synthesizes current evidence on LBBAP in CHD, including anatomical considerations of the conduction system, lead selection between lumenless and stylet‐driven leads, technical modifications for different substrates, and clinical outcomes. In congenitally corrected transposition of the great arteries (CCTGA), the paradoxically anterior conduction system creates favorable anatomy for LBBAP, with reported success rates of 86%–100% in small observational series. CHD‐specific data from Moore et al. demonstrated superior QRS narrowing with conduction system pacing (CSP) compared to conventional CRT (35 vs. 14 ms; p = 0.04). One randomized trial and multiple meta‐analyses comparing lumenless and stylet‐driven leads demonstrate comparable success rates but distinct safety profiles, with implications for lead choice in CHD patients requiring lifelong pacing. The 2023 HRS/APHRS/LAHRS and 2025 ACC/AHA guidelines now recognize CSP as a therapeutic option in selected patients, though these endorsements are not specific to LBBAP in CHD. CHD‐specific evidence remains limited to case series and small observational studies. This review provides a practical framework for patient selection, lead choice, and procedural planning while identifying key research priorities for this growing patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart Defects, CongenitalCardiac Pacing, ArtificialBundle of HisHumans

Stichwörter der Autor:innen

cardiac resynchronization therapyconduction system pacingcongenital heart diseasecongenitally corrected transpositionleft bundle branch area pacinglumenless leadsstylet‐driven leadssystemic right ventricle

Autor:innen und Institutionen

  • Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine, Yahaba, Japan.

ORCID-Profile: Reisuke Yoshizawa

Zitieren

APA

Yoshizawa, R. (2026). Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions. Pacing and Clinical Electrophysiology, 49(11), 1772-1781. https://doi.org/10.1111/pace.70402

Vancouver

Yoshizawa R. Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions. Pacing and Clinical Electrophysiology. 2026;49(11):1772-1781. doi:10.1111/pace.70402

BibTeX
@article{Yoshizawa2026,
  author = {Yoshizawa, Reisuke},
  title = {Left Bundle Branch Area Pacing in Congenital Heart Disease: Current Evidence, Challenges, and Future Directions},
  journal = {Pacing and Clinical Electrophysiology},
  year = {2026},
  volume = {49},
  number = {11},
  pages = {1772--1781},
  doi = {10.1111/pace.70402}
}
Kostenlos starten →